{"database": "openregs", "table": "federal_register", "rows": [["2010-11245", "Oral Dosage Form New Animal Drugs; Orbifloxacin Suspension", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Intervet, Inc. The NADA provides for the veterinary prescription use of an oral suspension containing orbifloxacin for the treatment of various bacterial infections in dogs and cats.", "2010-05-12", 2010, 5, "https://www.federalregister.gov/documents/2010/05/12/2010-11245/oral-dosage-form-new-animal-drugs-orbifloxacin-suspension", "https://www.govinfo.gov/content/pkg/FR-2010-05-12/pdf/2010-11245.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Intervet, Inc. The NADA provides for the veterinary prescription use of an oral suspension containing...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2010-11245"], "units": {}, "query_ms": 110.91185896657407, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}